SVA Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $1.88M | Sell |
32,341
-6,506
| -17% | -$379K | 0.16% | 101 |
|
|
2020
Q3 | $2.46M | Sell |
38,847
-3,307
| -8% | -$209K | 0.24% | 82 |
|
|
2020
Q2 | $3.24M | Buy |
42,154
+2,900
| +7% | +$223K | 0.35% | 62 |
|
|
2020
Q1 | $2.94M | Buy |
39,254
+5,382
| +16% | +$402K | 0.34% | 56 |
|
|
2019
Q4 | $2.2M | Sell |
33,872
-74
| -0.2% | -$4.81K | 0.2% | 92 |
|
|
2019
Q3 | $2.15M | Buy |
33,946
+493
| +1% | +$31.2K | 0.21% | 91 |
|
|
2019
Q2 | $2.26M | Sell |
33,453
-399
| -1% | -$27K | 0.22% | 87 |
|
|
2019
Q1 | $2.2M | Buy |
33,852
+5,801
| +21% | +$377K | 0.21% | 92 |
|
|
2018
Q4 | $1.76M | Sell |
28,051
-4,990
| -15% | -$312K | 0.2% | 94 |
|
|
2018
Q3 | $2.55M | Buy |
+33,041
| New | +$2.55M | 0.26% | 80 |
|
|
2018
Q2 | – | Sell |
-2,720
| Closed | -$220K | – | 219 |
|
|
2018
Q1 | $220K | Buy |
+2,720
| New | +$220K | 0.03% | 195 |
|
|
2017
Q4 | – | Sell |
-2,720
| Closed | -$220K | – | 206 |
|
|
2017
Q3 | $220K | Buy |
+2,720
| New | +$220K | 0.03% | 195 |
|
|
2017
Q2 | – | Sell |
-2,970
| Closed | -$202K | – | 201 |
|
|
2017
Q1 | $202K | Sell |
2,970
-388
| -12% | -$26.4K | 0.03% | 190 |
|
|
2016
Q4 | $240K | Sell |
3,358
-58
| -2% | -$4.15K | 0.04% | 182 |
|
|
2016
Q3 | $270K | Buy |
3,416
+557
| +19% | +$44K | 0.04% | 170 |
|
|
2016
Q2 | $238K | Hold |
2,859
| – | – | 0.04% | 179 |
|
|
2016
Q1 | $263K | Buy |
2,859
+172
| +6% | +$15.8K | 0.04% | 175 |
|
|
2015
Q4 | $272K | Buy |
+2,687
| New | +$272K | 0.05% | 188 |
|